VG Acquisition Corp.

The deal values 23andMe at approximately $3.5 billion through the combination of stock and cash financing.
By  Mallory Hackett 11:56 am February 4, 2021
Consumer genomics platform 23andMe is on its way to becoming a publicly-traded company through its merger with VG Acquisition Corp., a special purpose acquisition company sponsored by Virgin Group. The two companies announced today they have entered into a definitive merger agreement that is expected to close in the second quarter of this year. Once completed, the combined companies’ stock will...